Franz Obermayr
Chief Executive Officer bei Panoptes Pharma GmbH
Profil
Franz Obermayr is the founder and Chief Executive Officer of Panoptes Pharma GmbH since 2013.
He was also the Head of Clinical Development at Nabriva Therapeutics Plc from 2009 to 2013.
In addition, he served as Director of Drug Discovery at GPC Biotech, Inc. Dr. Obermayr was also the Executive Vice President of Clinical Development at Kiora Pharmaceuticals, Inc. in 2021.
Aktive Positionen von Franz Obermayr
| Unternehmen | Position | Beginn |
|---|---|---|
Panoptes Pharma GmbH
 Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Chief Executive Officer | 01.07.2013 |
Ehemalige bekannte Positionen von Franz Obermayr
| Unternehmen | Position | Ende |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Chief Executive Officer | 26.07.2021 |
| NABRIVA THERAPEUTICS PLC | Corporate Officer/Principal | 01.01.2013 |
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| NABRIVA THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Retail Trade |
Panoptes Pharma GmbH
Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Health Technology |
